These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1045 related items for PubMed ID: 26228050

  • 1. Treatment of chronic HCV genotype 1 coinfection.
    Boesecke C, Rockstroh JK.
    Curr HIV/AIDS Rep; 2015 Sep; 12(3):326-35. PubMed ID: 26228050
    [Abstract] [Full Text] [Related]

  • 2. HIV Coinfected Have Similar SVR Rates as HCV Monoinfected With DAAs: It's Time to End Segregation and Integrate HIV Patients Into HCV Trials.
    Shafran SD.
    Clin Infect Dis; 2015 Oct 01; 61(7):1127-34. PubMed ID: 26060286
    [Abstract] [Full Text] [Related]

  • 3. HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort study.
    Neukam K, Morano-Amado LE, Rivero-Juárez A, Mancebo M, Granados R, Téllez F, Collado A, Ríos MJ, de Los Santos-Gil I, Reus-Bañuls S, Vera-Méndez F, Geijo-Martínez P, Montero-Alonso M, Suárez-Santamaría M, Pineda JA.
    HIV Clin Trials; 2017 May 01; 18(3):126-134. PubMed ID: 28599618
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.
    Miailhes P, Hartig-Lavie K, Virlogeux V, Pradat P, Diakite M, Uhres AC, Zoulim F, Sarda MN.
    Clin Microbiol Infect; 2018 Nov 01; 24(11):1215.e1-1215.e4. PubMed ID: 29870852
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Future of hepatitis C therapy: development of direct-acting antivirals.
    Dore GJ, Matthews GV, Rockstroh J.
    Curr Opin HIV AIDS; 2011 Nov 01; 6(6):508-13. PubMed ID: 21897228
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?
    Bischoff J, Mauss S, Cordes C, Lutz T, Scholten S, Moll A, Jäger H, Cornberg M, Manns MP, Baumgarten A, Rockstroh JK.
    HIV Med; 2018 Apr 01; 19(4):299-307. PubMed ID: 29368456
    [Abstract] [Full Text] [Related]

  • 16. Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.
    Poizot-Martin I, Naqvi A, Obry-Roguet V, Valantin MA, Cuzin L, Billaud E, Cheret A, Rey D, Jacomet C, Duvivier C, Pugliese P, Pradat P, Cotte L, Hepadat'AIDS Study Group.
    PLoS One; 2015 Apr 01; 10(10):e0141164. PubMed ID: 26488159
    [Abstract] [Full Text] [Related]

  • 17. Treatment of genotype 1 HCV infection in the HIV coinfected patient in 2014.
    Chastain CA, Naggie S.
    Curr HIV/AIDS Rep; 2013 Dec 01; 10(4):408-19. PubMed ID: 24272069
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients.
    Del Bello D, Ita Nagy F, Hand J, Khedemi R, Lécluse-Barth J, Dieterich D, Piroth L.
    Curr Opin HIV AIDS; 2015 Sep 01; 10(5):337-47. PubMed ID: 26248121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.